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The Cytoplasmic Domain of Xenopus NF-Protocadherin
Interacts with TAF1/Set
members of the family, several additional proteins have
been identified and classified within the cadherin family,
many of which exhibit interesting expression patterns
Mike A. Heggem and Roger S. Bradley*
Department of Cell Biology and Neuroscience
Montana State University
that implicate them in important developmental eventsBozeman, Montana 59717
(Angst et al., 2001). Of particular interest are the proto-
cadherins, which comprise a large subfamily of mole-
cules only distantly related to classical cadherins, toSummary
which they share homology solely in their extracellular
domain (Frank and Kemler, 2002; Sano et al., 1993; Su-Protocadherins are members of the cadherin super-
zuki, 2000). Rather than five cadherin repeats typical offamily of cell adhesion molecules proposed to play
classical cadherins, the number of extracellular repeatsimportant roles in early development, but whose
in protocadherins is often six to seven; furthermore, themechanisms of action are largely unknown. We exam-
cytoplasmic domains of protocadherins are not relatedined the function of NF-protocadherin (NFPC), a novel
to classical cadherins and represent novel sequence, andcell adhesion molecule essential for the histogenesis
hence little is known concerning interacting cytosolic pro-of the embryonic ectoderm in Xenopus, and demon-
teins. Interestingly, protocadherin family members arestrate that the cellular protein TAF1, previously identi-
highly expressed in the nervous system in vertebrates,fied as a histone-associated protein, binds the NFPC
and are proposed to participate in the subdivision ofcytoplasmic domain. NFPC and TAF1 coprecipitate
the brain into functional domains, as well as in the forma-from embryo extracts when ectopically expressed,
tion of neural circuits (Arndt and Redies, 1998; Hiranoand TAF1 can rescue the ectodermal disruptions
et al., 1999). Despite their proposed roles, relatively fewcaused by a dominant-negative NFPC construct lack-
studies have addressed the function of protocadherinsing the extracellular domain. Furthermore, disruptions
during development.in either NFPC or TAF1 expression, using NFPC- or
We previously isolated a novel protocadherin fromTAF1-specific antisense morpholinos, result in essen-
Xenopus, termed NF-protocadherin (NFPC; Bradley ettially identical ectodermal defects. These results indi-
al., 1998), which exhibits a restricted expression patterncate a role for TAF1 in the differentiation of the embry-
in early embryos, being predominantly localized to theonic ectoderm, as a cytosolic cofactor of NFPC.
inner or sensorial layer of the ectoderm, as well as to a
subset of cells in the neural folds and neural tube. ThisIntroduction
expression pattern implied a role for NFPC in cell adhe-
sion during embryonic ectodermal differentiation, whichThe cadherins comprise a large family of calcium-
was subsequently confirmed by studies designed todependent cell adhesion molecules whose members are
misexpress NFPC in early embryos. Ectopic expressioninvolved in important morphogenic events throughout
of wild-type NFPC, by RNA injection, demonstrated thatembryogenesis. Cadherin-mediated cell adhesion has
NFPC can mediate cell adhesion within the embryonicbeen implicated in diverse developmental processes,
ectoderm in vivo. In contrast, ectopic expression of afrom cell migration and the sorting of embryonic cells
dominant-negative form of NFPC, in which the entireinto tissues to the formation of synaptic junctions and
extracellular domain is deleted (NFE), significantly per-the establishment of complex neural circuits (Gumbiner,
turbs ectoderm differentiation, resulting in the formation1996; Shapiro and Colman, 1999; Takeichi et al., 1997;
of large ectodermal blisters pursuant to the dissociation
Tepass et al., 2000). The original members of this family,
of cells in the inner layer.
the classical cadherins, are localized to sites of cell-cell
While not directly addressed in the previous study,
contact at the adherens junction, where they function several lines of evidence strongly suggest that cyto-
as dimers, each dimer binding two identical dimers in plasmic cofactors are essential for NFPC-mediated cell
a neighboring cell (Koch et al., 1999; Pertz et al., 1999). adhesion, and that these factors are distinct from those
Classical cadherins are transmembrane proteins, with that bind classical cadherins. First, removing the intra-
an extracellular domain containing five tandem cad- cellular domain of NFPC abrogates its ability to promote
herin-specific repeats and a highly conserved intra- cell adhesion, demonstrating that the cytoplasmic do-
cellular domain. Several intracellular proteins promote main is critical for NFPC function (Bradley et al., 1998).
adherens junction formation by binding to conserved Second, the ability of the intracellular domain of NFPC
regions of the classical cadherin cytoplasmic domain. to act as a dominant-negative, causing dissociation of
These include the catenins (-, -, and -catenin), which the ectodermal inner layer, is presumably due to compe-
govern the interaction of cadherins with the cytoskele- tition with endogenous NFPC for binding intracellular
ton, the src substrate p120ctn, thought to mediate lateral cofactors. Third, the mouse and human homologs of
clustering of cadherins, and IQGAP1, a target of the Rho NFPC (termed BH-protocadherin; Yoshida et al., 1998,
family of small GTPases (Gumbiner, 2000; Kuroda et al., 1999) exhibit striking amino acid conservation in their
1998; Yap et al., 1998). cytosolic domain, implying that the function of this do-
While classical cadherins remain the best-studied main has been conserved across vertebrates. Finally,
as the cytoplasmic domain of NFPC is not homologous
to other cadherins and does not contain the consensus*Correspondence: rbradley@montana.edu
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Figure 1. Ectopic Expression of NFPC Dominant-Negative Constructs in the Ectoderm
(A) Schematic diagram of NFPC dominant-negative mutants. In NFE, the NFPC extracellular domain is deleted, constructs NF5, NF4,
NF3, NF2, and NF1 delete increasing regions of the C terminus of NFE, while NFN deletes 71 amino acids from the juxtamembrane
domain. All constructs are tagged at the C terminus with an RGS-His6 epitope (HT).
(B) Immunoblot analysis of NFPC deletion constructs expressed in embryos. Embryos were injected with RNA encoding the indicated deletion
construct, and then harvested at stage 14 and analyzed by Western blot with an anti-His antibody. All deletion constructs were expressed in
embryos at expected molecular masses.
(C–H) Ectopic expression of NF5-HT, NF4-HT, and NF3-HT in ectoderm. Embryos were coinjected with RNA encoding either NF5-HT
(C), NF4-HT (D), or NF3-HT (E) together with nLacZ RNA, fixed at stage 14, and stained for -galactosidase activity. Compared to control
embryos injected with nLacZ RNA alone (F), embryos injected with NF5-HT or NF4-HT developed large ectodermal blisters (outline), while
embryos injected with NF3-HT exhibit less pronounced ectodermal disruptions. Embryos were injected with NF4-HT (G) or NF3-HT (H),
and then immunostained for the His epitope tag and sectioned, revealing the ectodermal blistering.
(I) Control embryo injected with nLacZ RNA.
catenin binding site identified in classical cadherins of either antisense TAF1 or NFPC morpholinos results
in morphologically identical ectodermal defects due, in(Stappert and Kemler, 1994), NFPC is unlikely to interact
with catenins and may mediate cell adhesion via novel part, to a decrease in programmed cell death in the
ectoderm. These findings indicate that TAF1 may partici-mechanisms. Therefore, to ascertain the mechanism of
action of NFPC as a cell adhesion molecule, we sought pate in NFPC-mediated cell adhesion in the embryonic
ectoderm, and that both NFPC and TAF1 are requiredto identify proteins that interact with the cytoplasmic
domain of NFPC. Results presented here demonstrate for the proper differentiation of this tissue.
that the NFPC juxtamembrane domain interacts with a
protein, TAF1, previously identified as a histone binding Results
protein involved in mediating transcriptional access to
chromatin. In Xenopus, TAF1 is normally expressed in Deletion Analysis of the NFPC
Cytoplasmic Domainthe embryonic ectoderm and neural tube, and NFPC
coprecipitates with TAF1 when ectopically expressed Ectopic expression of a mutant NFPC construct lacking
the extracellular domain (NFE) was previously shownin embryos. In addition, coinjection of TAF1 and NFE
can rescue the ectodermal blisters observed upon ec- to disrupt the embryonic ectoderm, resulting in the for-
mation of ectodermal blisters (Bradley et al., 1998). Thistopic expression of NFE alone. Furthermore, injection
NFPC and TAF1 Interaction in the Ectoderm
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Table 1. Ectodermal Blisters Produced by NFPC Dominant-Negative Mutants
Number of Number of Percentage of
RNA injected embryos examined embryos with blisters embryos with blisters
NF1-HT 83 2 2.4
NF2-HT 94 13 13.8
NF3-HT 117 22 18.8
NF4-HT 178 75 42.1
NF5-HT 131 87 66.4
NFN-HT 45 0 0
NFE-HT 99 59 59.6
nLacZ 115 0 0
Embryos were injected with RNA encoding deletion constructs, along with nLacZ to mark the site of injection, fixed at stage 14, stained in
X-gal, and examined for the appearance of ectodermal blisters.
dominant-negative activity of NFE allowed a conve- glutathione-agarose. HeLa cells were chosen because
expression of NFPC in HeLa cells, by stable transfection,nient assay to map regions of the NFPC cytoplasmic
domain necessary for cell adhesion. Accordingly, sev- results in targeting of NFPC to the plasma membrane
where it becomes concentrated at sites of cell-cell con-eral mutant forms of NFE were generated, lacking vari-
ous portions of the intracellular domain, for ectopic ex- tact (data not shown), indicating that HeLa cells contain
cofactors necessary for NFPC-mediated cell adhesion.pression in Xenopus embryos (Figure 1A). Injection of
RNA encoding these constructs, tagged with a His epi- Proteins that bound the fusion constructs were then
analyzed by SDS-PAGE followed by silver staining, re-tope (HT) followed by immunoblot analysis of embryo
extracts with an epitope-specific antibody, established vealing several proteins that potentially interact with the
NFPC cytoplasmic domain (Figure 2A). Initial efforts tothat all constructs were expressed in embryos at the
expected molecular mass (Figure 1B). In addition, isolate interacting proteins have focused on the most
prominent of these, the 41 and 39 kDa polypeptides,whole-mount immunochemical staining of injected em-
bryos revealed that all constructs were appropriately both of which interact with constructs containing re-
gions necessary for the dominant-negative effectexpressed and localized to the plasma membrane (data
not shown). These deletion constructs were then as- (NF3-GST and NF5-GST) but bind more weakly to
NF2-GST, and not with NFN-GST or a control frame-sayed for their ability to function as dominant-negatives,
similar to NFE, perturbing the formation of the embry- shifted construct encoding a nonsense protein that ter-
minates after 12 amino acids (NFfs-GST). Thus, bindingonic ectoderm. Embryos were injected with RNA encod-
ing the deletion constructs, along with nLacZ to mark of the 41 and 39 kDa polypeptides to the GST-fusion
proteins requires the juxtamembrane region of the NFPCthe site of injection, allowed to develop until neural plate
stage (stage 14), and examined for ectodermal blisters. cytoplasmic domain, the same region required as a
dominant-negative in the ectodermal blister assay.Constructs in which up to 58 amino acids of the C termi-
nus were deleted (NF5-HT and NF4-HT) still function To isolate and identify the 41 and 39 kDa proteins,
the above procedure was scaled up and the two poly-as strong dominant-negatives upon expression in Xeno-
pus embryos, resulting in the formation of ectodermal peptides were excised and subjected to trypsin diges-
tion. Resultant peptides were sequenced and used toblisters (Figure 1; Table 1). In contrast, deletion of either
79 or 107 amino acids from the C terminus (NF3-HT search the NRPD. One protein in the database, human
TAF1/Set, matched peptides obtained from both the 41and NF2-HT) produced increasingly weaker perturba-
tions of the embryonic ectoderm, while deletion of the and 39 kDa proteins. The TAF1 protein was originally
identified as a putative oncogene activated by a translo-C-terminal 142 amino acids (NF1-HT) resulted in an
almost complete loss of the dominant-negative activity. cation breakpoint in acute undifferentiated leukemia and
was reported to be a nuclear transcription/replicationSimilarly, a construct that deleted the juxtamembrane
71 amino acids of the cytoplasmic domain (NFN-HT) factor (Adachi et al., 1994; Nagata et al., 1995). Consis-
tent with the results from the pull-down experiments,had no effect on the embryonic ectoderm. Thus, the
ability of NFE to act as a dominant-negative maps to TAF1 exists as two alternatively spliced isoforms  and
, of approximate MW 41 and 39 kDa, respectively,the first 80 amino acids of the cytoplasmic domain of
NFPC. This region, therefore, plays an important role in which differ at the N-terminal AUG used for translation
(Figure 2B).NFPC-mediated adhesion and likely contains sites for
interacting cytosolic factors. To confirm that TAF1 is the identity of the 41 and 39
kDa peptides that bind GST-NF3, we performed an
immunoblot analysis of the GST-fusion pull-downs, us-Identification of Proteins Associated
with the NFPC Cytoplasmic Domain ing an antisera against human TAF1 protein. As shown
in Figure 2C, the 39 kDa band was detected in the GST-This deletion analysis was then used as a starting point
for identifying proteins that bind the NFPC cytoplasmic NF3 lane, but not in the control GST-NFN lane. This
confirms that TAF1 is the 39 kDa protein that binds todomain. GST-fusion proteins were generated containing
the cytoplasmic domains of NF2, NF3, NF5, and the cytoplasmic domain of NFPC. As this antiserum was
raised to an N-terminal peptide specific to the 39 kDaNFN, and cytosolic extracts from cultured HeLa cells
were then incubated with the fusion proteins bound to isoform, it does not recognize the 41 kDa TAF1 protein.
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Figure 2. TAF1 Binds the NFPC Juxtamem-
brane Domain
(A) Proteins that bind the NFPC cytoplasmic
domain. HeLa cell extracts were incubated
with GST-fusion constructs, and bound pro-
teins were eluted and analyzed by SDS-PAGE
and silver stained. The 41 and 39 kDa proteins
bind NF3-GST, NF5-GST (partially ob-
scured by the GST-fusion protein band
marked by an asterisk), and to a lesser extent
NF2-GST, but not NFfs-GST or NFN-GST.
(B) The 41 and 39 kDa proteins bound by
NF3-GST are identical to human TAF1. The
amino acid sequence of human TAF1, includ-
ing the two alternatively spliced products that
differ only at their N terminus, is shown. The
two proteolytic fragments identified by micro-
sequencing are underlined.
(C) Immunoblot analysis of interacting pro-
teins. HeLa cell extracts were incubated with
NF3-GST or NFN-GST, and bound proteins
were eluted and analyzed by SDS-PAGE fol-
lowed by Western blotting with anti-TAF1
antibody. The 39 kDa TAF1 protein binds to
NF3-GST, but not the control NFN-GST. A
27 kDa peptide is also detected by the anti-
body, and may represent a proteolytic frag-
ment of TAF1.
NFPC and TAF1 Interact In Vivo a His-tagged TAF1 (TAF1-HT) were coinjected into a
single blastomere at the four-cell stage. Embryos wereAs TAF1 has previously been described as a nuclear
protein, the specificity of the interaction between the allowed to develop until stage 14, dounced in lysis
buffer, and TAF1-HT was precipitated by the additionNFPC cytoplasmic domain and TAF1 was not immedi-
ately obvious and required further testing. Therefore, to of Ni-NTA-agarose. Proteins bound to Ni-NTA-agarose
were then analyzed by SDS-PAGE followed by immu-confirm that TAF1 can interact with NFPC in vivo, we
next examined the subcellular distribution of TAF1 by noblotting with the myc antibody. As shown in Figure
4, while neither NFE-MT nor NFPC-MT is precipitatedindirect immunofluorescence. HeLa cells were trans-
fected with a construct encoding a myc epitope-tagged by Ni-NTA-agarose in the absence of TAF1-HT, in coin-
jected embryos both NFE-MT and NFPC-MT coprecip-NFPC (NFPC-MT) and stained for expression of the myc
epitope and for human TAF1. Results reveal that while itate with TAF1-HT. To confirm the interaction of NFPC
and TAF1, we next asked whether endogenous TAF1TAF1 is primarily restricted to the nucleus, in approxi-
mately 40% of transfected cells, a fraction of TAF1 can can associate with NFPC. Therefore, embryos were in-
jected with RNA encoding wild-type NFPC, harvestedbe seen at the cell membrane between two adjacent
cells expressing NFPC-MT, where it colocalizes with at stage 19, and immunoprecipitated with an anti-TAF1
monoclonal antibody. As shown in Figure 4C, NFPCNFPC-MT (Figures 3B and 3C, and data not shown). In
contrast, in HeLa cells transfected with a myc-tagged does coprecipitate with endogenous TAF1, consistent
with TAF1 acting as a cytosolic cofactor of NFPC.N-cadherin construct (N-Cad-MT), no TAF1 protein is
seen at the membrane (Figure 3D). This suggests that
TAF1 is not found exclusively in the nucleus in cells in NFE-Induced Blisters Are Rescued by TAF1
While the above results suggest that NFPC and TAF1culture, but in the presence of NFPC can localize to the
plasma membrane, supporting the idea that TAF1 can can interact in vivo, it was not known whether TAF1 is
required for NFPC-mediated cell adhesion. To addressinteract with the cytoplasmic domain of NFPC.
To determine whether TAF1 can interact with NFPC this question, we sought to determine whether ectoder-
mal blisters, as caused by the dominant-negative NFE,in vivo in embryos, we next sought to coprecipitate
NFPC and TAF1 from Xenopus embryos. RNA encoding result from the sequestering of endogenous TAF1 by
NFE. Thus, we asked whether coinjection of Xenopusmyc epitope-tagged NFE (NFE-MT) or NFPC-MT and
NFPC and TAF1 Interaction in the Ectoderm
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Figure 3. NFPC and TAF1 Colocalize at the Plasma Membrane
HeLa cells were transfected with DNA encoding NFPC-MT or N-Cad-MT, and then processed by immunofluorescence with antibodies to
human TAF1 (A and D) and the myc epitope (B and E), and viewed by confocal microscopy. While TAF1 is restricted to the nucleus in cells
transfected with N-Cad-MT (D), in cells transfected with NFPC-MT, TAF1 is also found at the membrane where it colocalizes with NFPC
(arrows).
(C and F) Merged fluorescence of (A) and (B), and (D) and (E), respectively.
TAF1 RNA rescues the blisters produced by NFE. As layer by stage 17 (Figure 5A; Bradley et al., 1998). Inter-
estingly, TAF1 reveals a similarly restricted expressionsummarized in Table 2, injection of NFE RNA alone
resulted in 40% of embryos exhibiting ectodermal blis- pattern at stage 17, with TAF1 most highly expressed
in the inner layer of the epidermis (Figure 5B). To confirmters, whereas coinjection of NFE and TAF1 RNA re-
sulted in only 2% of embryos with blisters. Thus, coinjec- that TAF1 protein is indeed present in ectodermal cells
and to examine its subcellular distribution, we next uti-tion of TAF1 RNA can reduce the incidence of
ectodermal blisters observed with NFE RNA alone. lized a monoclonal antibody generated against human
TAF1 and -, previously shown to recognize XenopusThis implies that TAF1 does act as a cytosolic cofactor
of NFPC-mediated cell adhesion, at least within the em- TAF1 (Matsumoto et al., 1999), to label whole-mount
embryos. As shown in Figure 5D, endogenous TAF1bryonic ectoderm, and that the dominant-negative ef-
fect of NFE is due, in part, to the sequestering of endog- protein is present in the ectodermal cells in both the
nucleus and at the cell membrane, consistent with aenous TAF1 protein.
role for TAF1 as a cofactor of NFPC. Thus both NFPC
and TAF1 are normally expressed in the ectoderm,TAF1 Is Required for Proper
Ectodermal Development where they may interact at the cytoplasmic face of the
cell membrane to regulate the differentiation of thisCoprecipitation and rescue studies described above in-
dicate that TAF1 may be one of the cofactors neces- tissue.
To test whether TAF1 is required for proper ectoder-sary for NFPC-mediated cell adhesion in the embryonic
ectoderm. As the expression pattern of Xenopus TAF1 mal development, we sought to disrupt the expression of
TAF1 in the ectoderm by injecting an antisense TAF1has not been described, we sought to determine
whether TAF1 is also expressed in the ectoderm, simi- morpholino (TAF1MO) into embryos. As shown in Fig-
ure 5, embryos injected with the TAF1MO exhibit de-lar to NFPC, at the relevant developmental stages at
which NFPC is thought to function during ectodermal fects in the normal two-cell layered ectoderm, resulting
in an ectodermal bulge, which appears to result fromdevelopment. Therefore, TAF1 RNA expression was
localized in early embryos by whole-mount in situ hy- an increase in cells within the ectoderm. In addition,
cellular morphology appears altered by the morpholino,bridization. Prior to gastrulation, TAF1 is expressed at
low levels throughout the ectoderm, which subsequently as the ectodermal cells lose their cuboidal shape and
become more spherical. Significantly, this phenotype isincreases to give strong staining in the ectoderm and
neural plate (Figure 5 and data not shown). A control in almost identical to that caused by an antisense NFPC
morpholino (NFPCMO), whereas embryos injected withsitu hybridization with a sense TAF1 probe showed no
detectable staining (data not shown). a control morpholino (CMO) exhibit no ectodermal dis-
ruptions. To verify that TAF1MO and NFPCMO wereThe ectoderm of Xenopus is unusual in that it consists
of two layers, an inner cell layer (sensorial layer) and effective in preventing expression of their respective
proteins, morpholino-injected embryos were douncedan outer cell layer (epithelial layer), and our previous
research established that NFPC, while initially ex- in lysis buffer and extracts were analyzed by immunoblot
analysis for expression of Xenopus TAF1 and NFPC.pressed in both layers, becomes restricted to the inner
Developmental Cell
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Figure 4. Interaction of TAF1 and NFPC In
Vivo
(A) Embryos were injected with RNA encoding
either Xenopus TAF1-HT (lane 4), NFE-MT
(lanes 1 and 3), NFPC-MT (lanes 6 and 7),
or coinjected with TAF1-HT and NFE-MT
(lane 5) or NFPC-MT (lane 8). Embryos were
lysed at stage 14, and incubated with Ni-NTA-
agarose to precipitate TAF1-HT (lanes 2–5,
7, and 8). Bound proteins were then analyzed
by immunoblot with an antibody to the myc
epitope tag. NFE-MT and NFPC-MT are pre-
cipitated only in embryos coinjected with
TAF1-HT (lanes 5 and 8).
(B) Precipitated extracts from (A) immu-
noblotted with the anti-His antibody reveal
that TAF1-HT is precipitated by Ni-NTA.
(C) Embryos were injected with RNA encod-
ing a nonepitope-tagged NFPC, lysed at
stage 19, and immunoprecipitated with either
a monoclonal antibody to TAF1 to precipi-
tate endogenous TAF1 (lane 4), or a control
monoclonal antibody (lane 3). Subsequent
immunoblotting with an antibody to TAF1 or
Xenopus NFPC reveals that NFPC coprecipi-
tates with endogenous TAF1.
Whereas uninjected and CMO-injected embryos ex- NFPCMO or TAF1MO, together with nLacZ RNA, and
then fixed at stage 22, stained for -galactosidase activ-press similar levels of TAF1 and NFPC, embryos in-
jected with TAF1MO or NFPCMO exhibit a significant ity, and subjected to whole-mount TUNEL labeling. La-
beled embryos were then serially sectioned and exam-decrease in TAF1 and NFPC protein levels, respec-
tively (Figure 5H). Thus both TAF1MO and NFPCMO are ined for TUNEL-positive cells in the ectoderm. Results
reveal that both NFPCMO and TAF1MO cause a reduc-effective in reducing the amount of their corresponding
proteins present in embryos, and both cause an appar- tion in apoptosis in the ectoderm as compared to CMO-
injected embryos (Figures 5I–5K). Quantification of cellent excess of cells in the embryonic ectoderm.
To confirm that the two morpholinos result in similar death was obtained from sectioned embryos by count-
ing the number of TUNEL-positive nuclei in the injecteddefects, and to investigate the nature of the ectodermal
bulges, we next sought to determine whether TAF1MO side of the ectoderm (as determined by X-gal staining).
Compared to CMO-injected embryos, embryos injectedand NFPCMO cause an increase in cell proliferation and/
or survival, either of which could result in an increase with either NFPCMO or TAF1MO show a marked reduc-
tion in TUNEL-positive nuclei (Figure 5L). This suggestsin ectodermal cells. Therefore, to determine whether
ectodermal cell mitosis is altered by the morpholinos, that the ectodermal defects caused by NFPCMO and
TAF1MO are due, at least in part, to a decrease in cellembryos were injected with NFPCMO or TAF1MO, al-
lowed to develop until stage 22, and then injected with death, and provides further evidence that NFPC and
TAF1 play interrelated roles in the ectoderm.BrdU to label cells undergoing DNA synthesis. Subse-
quent analysis of BrdU-labeled nuclei in the ectoderm
revealed no obvious difference between NFPCMO- and
TAF1MO-injected embryos as compared to control Discussion
embryos (data not shown). We next sought to determine
whether cell survival in the ectoderm was altered by Protocadherins comprise a large family of develop-
mentally regulated molecules thought to be involved inNFPCMO or TAF1MO. Embryos were coinjected with
Table 2. Rescue of NFE-Induced Blisters by Xenopus TAF1
Number of Number of Percentage of
RNA injected embryos examined embryos with blisters embryos with blisters
NFE-HT 168 72 43
NFE-HT TAF1 175 4 2
TAF1 149 0 0
Embryos were injected with RNA encoding NFE or TAF1, or coinjected with NFE RNA and three times the amount of TAF1 RNA. Embryos
were then scored for the appearance of ectodermal blisters.
NFPC and TAF1 Interaction in the Ectoderm
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Figure 5. Xenopus TAF1 Is Expressed in the Embryonic Ectoderm and Is Required for Proper Ectodermal Differentiation
(A–C) Stage 17 embryos stained by in situ hybridization for NFPC (A) or TAF1 (B and C) and viewed in cross-section. TAF1 is expressed
in the neural plate (np), ventral ectoderm (ec), and presomitic mesoderm (psm). Within the ventral ectoderm, NFPC and TAF1 show similar
expression patterns, with both highly expressed in the inner layer (arrows).
(D) Stage 17 embryo immunostained with a TAF1 monoclonal antibody and viewed in whole-mount. TAF1 is expressed in both the nucleus
and at the cell membrane.
(E–H) Antisense NFPC and TAF1 morpholinos disrupt ectodermal differentiation. Embryos were coinjected with NFPCMO (E), TAF1MO (F),
or CMO (G), together with nLacZ RNA, fixed at stage 22, stained for -galactosidase activity, and sectioned. Compared to CMO-injected
embryos, embryos injected with NFPCMO or TAF1MO exhibit similar ectodermal defects.
(H) Immunoblot analysis of morpholino-injected embryos. Compared to uninjected (lane 1) or CMO-injected (lane 2) embryos, injection of
TAF1MO (lane 3) or NFPCMO (lane 4) significantly reduces the amount of TAF1 and NFPC protein present in the embryos, respectively.
(I–L) TUNEL assay for apoptotic nuclei in the ectoderm. Embryos were injected as in (E)–(G), stained for -galactosidase activity, and then
subjected to whole-mount TUNEL assay, sectioned, and analyzed for apoptotic nuclei (dark blue nuclei, arrowheads). NFPCMO-injected (I)
and TAF1MO-injected (J) embryos exhibit fewer apoptotic nuclei in the ectoderm, as compared to CMO-injected embryos (K).
(L) Results shown are the mean number of TUNEL-positive nuclei per section, averaged over 8–12 embryos per morpholino injection.
The following abbreviations were used: nc, notochord; sm, somite.
tissue morphogenesis. That at least some protocad- paraxial and axial domains, and in somite formation
(Kuroda et al., 2002; Kim et al., 1998, 2000). However,herins function as cell adhesion molecules has been
inferred from the sequence homology of their extracellu- little is known concerning the mechanism of action of
these, or other, protocadherins. Evidence presentedlar domains with that of classical cadherins. However,
despite the large number of protocadherins recently dis- here demonstrates that NFPC mediates cell adhesion
via novel mechanisms, utilizing the intracellular cofactorcovered, information on their roles in development has
been notably scarce. In Xenopus, NFPC is required for TAF1, and suggests that TAF1 plays a distinct role in
the development of the ectoderm in Xenopus. Whilethe proper formation of the embryonic ectoderm, and
two other protocadherins, Paraxial (PAPC) and Axial both human TAF1 and -are capable of interacting with
NFPC, as suggested by the GST pull-down experiments,protocadherin, also function in cell adhesion, playing
important roles in the subdivision of the mesoderm into we have only been able to isolate and test Xenopus
Developmental Cell
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TAF1 for its ability to bind NFPC. Whether a Xenopus Role of TAF1 in Embryonic Ectoderm
In situ hybridization results demonstrate that XenopusTAF1 isoform is expressed in early embryos remains
TAF1 is expressed in the inner layer of the embryonicto be determined, though Matsumoto et al. (1999) were
ectoderm, where it colocalizes with NFPC, and injectionalso unable to identify a TAF1 isoform from Xenopus
of either TAF1MO or NFPCMO results in virtually identi-egg extracts.
cal ectodermal defects, indicating that the two proteins
play interconnected roles in the differentiation of the
inner layer. In light of the previously reported functionsTAF1 Is a Cofactor of NFPC
of TAF1 in the nucleus and its ability to bind NFPC asGST pull-down experiments, as well as the coprecipita-
reported here, the question arises as to the exact roletion studies, indicate that TAF1 can bind the cyto-
of TAF1 in the ectoderm. Is TAF1 normally present atplasmic domain of NFPC. The region of the NFPC cyto-
the plasma membrane of the ectodermal inner cells,solic domain that interacts with TAF1 lies within the
where it functions as a required cofactor of NFPC, or ismembrane proximal 80 amino acids, as this region was
TAF1 present only in the nucleus under normal circum-found both to interact with TAF1 in the GST pull-down
stances? In the case of the former, the ectodermal blis-experiments and to be necessary for the disruption of
ters caused by expression of NFE are likely the resultthe embryonic ectoderm. This suggests that the domi-
of NFE competing with endogenous NFPC for the bind-nant-negative effect observed upon ectopic expression
ing of TAF1, thereby disrupting NFPC-mediated cellof NFE is due, in part, to competition with endogenous
adhesion. In the latter case, the NFE-induced ectoder-NFPC for the binding of intracellular TAF1, which is
mal blisters might be the result of NFE binding TAF1confirmed by the ability of ectopic TAF1 to rescue
and effectively removing TAF1 from the nucleus,the NFE-induced ectodermal blisters. Thus, TAF1 can
thereby altering the differentiation of the inner layer cells.function as a cytosolic cofactor of NFPC within the em-
We favor the former explanation for several reasons:bryonic ectoderm, and is necessary for proper NFPC
first, we have previously shown that the ectodermal blis-function. Interestingly, a construct in which all but the
ters are specific to NFE, in particular, ectopic expres-membrane proximal 20 amino acids are deleted (NF1)
sion of full-length NFPC does not affect the inner layercould slightly disrupt the ectoderm when expressed in
cells (Bradley et al., 1998). If blisters were caused solelyembryos, even though it was not capable of binding
by the removal of TAF1 from the nucleus, one wouldTAF1 (data not shown). While this region may not be
expect that ectopic expression of either NFPC or NFEdirectly involved in binding TAF1, it may still perturb
would result in the failure of the inner layer cells tothe binding of TAF1 to endogenous NFPC.
properly differentiate. Second, the NFE-induced de-TAF1/Set was originally identified as part of a fusion
fects can be rescued by ectopic expression of NFPCprotein activated in acute undifferentiated leukemia, and
(Bradley et al., 1998), indicating that it is competition forwas shown to be identical to the template activating
TAF1 binding the cytoplasmic domain of NFPC and thefactor 1 (TAF1), a host-derived protein required for ade-
resultant loss in NFPC-mediated cell adhesion, whichnoviral replication, where it is thought that TAF1 inter-
results in ectodermal blisters. Finally, our immunolocali-acts with viral basic core proteins to induce structural
zation results demonstrate that a subset of endogenouschanges in the adenoviral genome (Adachi et al., 1994;
TAF1 protein is normally present at the plasma mem-Nagata et al., 1995; von Lindern et al., 1992). TAF1 has
brane in ectodermal cells, where it could participatesince been identified as a component of the INHAT (in-
in NFPC-mediated cell adhesion. In this scenario, onehibitor of acetyltransferases) complex, which binds to
function of TAF1 may be to recruit Cdk5/p35nck5a to thehistones and blocks their acetylation (Seo et al., 2001). In
cell membrane, where it could phosphorylate NFPC oraddition, TAF1 interacts with the neuronal Cdk5 kinase
associated proteins, thereby modulating NFPC-medi-activation protein p35nck5a, and the activity of Cdk5/
ated adhesion. In fact, Cdk5/p35nck5a does localize to
p35nck5a is enhanced upon binding TAF1, leading to the
the membrane in neurons, where it can associate with
hypothesis that TAF1 may function to modulate protein
N-cadherin/-catenin complexes (Kwon et al., 2000). In
phosphorylation by Cdk5/p35nck5a (Qu et al., 2001). Thus, addition, Cdk5/p35nck5a can interact with Rac, a member
while the cellular role of TAF1 is not clearly defined, the of the Rho family of GTPases in neuronal growth cones
many functions ascribed to it, including the ability of (Nikolic et al., 1998). Thus, Cdk5/p35nck5a has been pro-
TAF1 to interact with NFPC, raises questions as to the posed to function in modulating cell adhesion and mi-
intracellular localization of TAF1. Immunolocalization gration in neurons, by altering N-cadherin-mediated cell
studies reveal that most TAF1 protein in a variety of adhesion and/or cytoskeletal components. Whether
cell types is found in the nucleus (Adachi et al., 1994), Cdk5/p35nck5a functions in NFPC/TAF1-mediated cell
suggesting that, at least in cells in culture, little TAF1 adhesion in the Xenopus ectoderm remains to be tested.
protein is found at the plasma membrane. Indeed, immu- Given the roles of TAF1 in the nucleus and as a
nolocalization of TAF1protein in HeLa cells transfected cofactor of NFPC, we cannot rule out that Xenopus
with Xenopus NFPC shows that the majority of TAF1 TAF1 may represent a link between NFPC-mediated
is nuclear; however, there is a subset of TAF1 found adhesion and changes in histone acetylation and tran-
at the cell membrane, where it colocalizes with NFPC. scriptional activation. A dual role for TAF1 is reminiscent
Similarly, in the Xenopus embryonic ectoderm, TAF1 of -catenin in classical cadherin-mediated cell adhe-
protein can be found in both the nucleus and at the cell sion, as -catenin not only binds to classical cadherins
membrane, suggesting that the localization of TAF1 at at the adherens junction but also can enter the nucleus
the plasma membrane may depend on the presence of in response to activation of the Wnt signaling pathway
(reviewed in Miller et al., 1999; Sharpe et al., 2001).functional NFPC.
NFPC and TAF1 Interaction in the Ectoderm
427
-catenin can exist in at least three pools within the cell, a more severe defect than that caused by disrupting
NFPC alone.one bound to classical cadherins at the cell membrane,
one bound to TCF transcription factors within the nu- In addition to the ectoderm inner cell layer, in situ
hybridization analysis demonstrated that Xenopuscleus, and a cytosolic pool that can respond to changes
in Wnt signaling or cellular adhesion. However, whether TAF1 is present throughout the early neural plate and
neural tube. NFPC, in comparison, is primarily restrictedchanges in cadherin-mediated cell adhesion can alter
the relative abundance of -catenin in the nucleus is to a subset of motor neurons in the ventral neural tube
(Bradley et al., 1998). What then is the role of TAF1 innot clear. Similarly, whether TAF1 can shift from a
membrane to nuclear localization in response to the cells that do not express NFPC? It is possible that
in these cells TAF1 functions independently of its rolechanges in cell adhesion has yet to be determined. A
detailed mapping of the TAF1 protein domains neces- in cell adhesion, as a component of INHAT; however, it
is also plausible that TAF1 may be a component of cellsary for INHAT activity versus binding to NFPC may help
elucidate its dual functions. For example, the ability of adhesion complexes mediated by other protocadherins.
Given the extensive size of the protocadherin family,TAF1both to promote adenovirus replication and partici-
pate in INHAT activity has been shown to require the it is likely that other protocadherins are expressed in
restricted regions of the neural tube, some of which mayacidic C-terminal domain. Furthermore, a mutant TAF1
lacking the C terminus no longer localizes to the nucleus, interact with TAF1. Further studies to identify proto-
cadherins expressed in the early nervous system, asbut is found predominantly in the cytoplasm (Matsumoto
et al., 1999; Nagata et al., 1998; Seo et al., 2001). Whether well as an analysis of their mechanisms of action, will
prove useful to understanding how protocadherins con-this region is also required for binding to NFPC is not
known. tribute to vertebrate neural development.
A requirement for TAF1 and NFPC in the embryonic
Experimental Proceduresectoderm is underscored by experiments to deplete the
two proteins during development. Injection of either the
Constructs and Antibodies
TAF1MO or NFPCMO causes similar defects: an ecto- NFPC, NFE, and N-cadherin constructs (Bradley et al., 1998) were
dermal bulge due to both an apparent increase in the subcloned into CS2MT (Turner and Weintraub, 1994) to give NFPC-
number of cells in the ectoderm as well as a change in MT, NFE-MT, and N-Cad-MT. NFE deletion constructs were gen-
erated by PCR, tagged with a C-terminal RGS-His6 epitope (HT),cell morphology. The increase in ectodermal cells is at
and subcloned into CS2. The Xenopus TAF1 coding region wasleast partially due to a decrease in programmed cell
obtained by PCR from a Xenopus stage 17 cDNA library (Kintnerdeath, a process that may be important for the histogen-
and Melton, 1987), tagged with a C-terminal HT, and subcloned into
esis of the epidermis. Generally, disruptions in cadherin- CS2 (TAF1-HT). NFPC antisera was generated by cloning the
mediated cell adhesion are associated with an increase cytoplasmic domain of Xenopus NFPC into the pQE vector (Qiagen),
in apoptosis in certain cell lines (Chen et al., 2002; Her- with the resultant fusion protein purified on a Ni-NTA-agarose (Qia-
gen) column and used to immunize rabbits.miston and Gordon, 1995; Kantak and Kramer, 1998).
Why NFPCMO and TAF1MO result in reduced apopto-
RNA Synthesis and Injectionsis is currently under investigation, though one possibil-
Synthesis and injection of RNA was performed as described (Bradley
ity is that by reducing NFPC-mediated cell adhesion, et al., 1998). For coprecipitation experiments, two-cell stage em-
the ectodermal cells remain in an undifferentiated state, bryos were injected with 10 pg RNA encoding NFPC-MT, NFE-
thereby preventing normal cell death associated with MT, and/or TAF1-HT, and then harvested at stage 14 and processed
as described. For rescue experiments, 10 pg NFE-HT RNA wasepidermal differentiation from occurring. While our evi-
injected alone or coinjected with three times the amount of Xenopusdence suggests that TAF1 functions in NFPC-mediated
TAF1 RNA into a single blastomere at the 16-cell stage, and thencell adhesion, at this point we cannot rule out the possi-
analyzed at stage 14 for NFE-induced blisters.
bility that NFPC and TAF1 have an independent role in
cell survival in the ectoderm. It is interesting to note that Immunoblot Analysis and Coprecipitation Experiments
the defects caused by either morpholino differ from the Injected embryos at stage 14 were dounced in lysis buffer A (10
mM HEPES [pH 7.4], 150 mM NaCl, 2 mM EDTA, 2 mM EGTA, 1%ectodermal blisters caused by NFE (Bradley et al.,
Triton X-100, 1 mM PMSF, 1 M aprotinin, 5 M leupeptin, 1.5 M1998). While ectopic expression of NFE results in a
pepstatin, 0.5 mM iodoacetamide, 15 M antipain, 3 mM benzami-loss of inner layer cells, NFPCMO and TAF1MO alter
dine) and spun at 10,000  g. For Western analysis, the above
ectodermal cell survival, resulting in an apparent in- supernatant was analyzed by SDS-PAGE and immunoblotted using
crease in ectodermal cells. This difference may be due to an anti-HT antibody (Qiagen) and ECL reagents (Amersham). For
the fact that the morpholinos and the dominant-negative coprecipitation studies, the supernatant fraction was incubated with
10 l of a 1:1 slurry of Ni-NTA-agarose (Qiagen) in lysis buffer B (10construct disrupt NFPC function by different mecha-
mM HEPES [pH 7.4], 150 mM NaCl, 2 mM CaCl2, 2 mM MgCl2, 20nisms: the morpholinos inhibit RNA translation, while
mM imidazole, 1% Triton X-100) for 30 min at 4C. Ni-NTA-agarosethe dominant-negative NFE construct blocks the inter-
was then pelleted by centrifugation, washed five times in buffer B,
action of TAF1, and possibly other cytosolic proteins, and stripped in Laemmli buffer. Bound proteins were analyzed by
with endogenous NFPC. It is possible that the dominant- immunoblot using the anti-myc monoclonal 9E10 (DSHB) or the anti-
negative is more effective at blocking NFPC function, HT antibody. Alternatively, NFPC RNA-injected embryos were lysed
and immunoprecipitated with an anti-TAF1 monoclonal antibodyparticularly because immunoblot analysis of embryos
(Matsumoto et al., 1999) followed by immunoblot analysis using theinjected with NFPCMO and TAF1MO demonstrate low
TAF1 monoclonal antibody or the rabbit NFPC antisera.levels of corresponding protein remaining in embryos.
Finally, it is also possible that NFE can block cell adhe- GST Pull-Downs and Microsequencing
sion mediated by related, as yet unidentified, protocad- Cytoplasmic deletion constructs of NFE were subcloned into
pGEX4T-3, expressed in BL21 bacteria, and the resultant GST-herins present in the embryonic ectoderm, resulting in
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fusion proteins purified on glutathione-agarose (Stratagene). Cyto- the translocation break point in acute undifferentiated leukemia. J.
Biol. Chem. 269, 2258–2262.solic extracts were prepared from 8 L of HeLa cells grown in spinning
culture and lysis of the cell pellet by douncing in 50 ml hypotonic Angst, B.D., Marcozzi, C., and Magee, A.I. (2001). The cadherin
lysis buffer (10 mM HEPES [pH 7.9], 10 mM KCl, 0.1 mM EDTA, 0.1 superfamily: diversity in form and function. J. Cell Sci. 114, 629–641.
mM EGTA, 2 mM DTT, 0.1 mM PMSF, 1M aprotinin, 5M leupeptin,
Arndt, K., and Redies, C. (1998). Development of cadherin-defined
1.5 M pepstatin, 3 mM benzamidine). Nuclei and insoluble material
parasagittal subdivisions in the embryonic chicken cerebellum. J.
were removed by centrifugation at 5000 rpm, and Triton X-100 was
Comp. Neurol. 401, 367–381.
added to the supernatant to a final concentration of 1%, followed
Bradley, R.S., Espeseth, A., and Kintner, C. (1998). NF-protocadh-by centrifugation. A 100 l aliquot of this second supernatant frac-
erin, a novel member of the cadherin superfamily, is required fortion was precleared with 25 l of glutathione-agarose for 1 hr, and
Xenopus ectodermal differentiation. Curr. Biol. 8, 325–334.then incubated with 25 l of one of the deletion constructs bound
to glutathione-agarose for 30 min at 4C. The agarose was then Chen, M.W., Vacherot, F., de la Taille, A., Gil-Diez-de-Medina, S.,
pelleted by centrifugation, washed in lysis buffer A, and the bound Shen, R., Friedman, R.A., Burchardt, M., Chopin, D.K., and Buttyan,
proteins were removed in Laemmli buffer and analyzed by SDS- R. (2002). The emergence of protocadherin-PC expression during
PAGE followed by silver staining, or by immunoblot using an anti- the acquisition of apoptosis-resistance by prostate cancer cells.
human TAF1 rabbit polyclonal (Adachi et al., 1994). Oncogene 21, 7861–7871.
For microsequencing, the above protocol was modified as follows: Fischer, W.H., Karr, D., Jackson, B., Park, M., and Vale, W. (1991).
500 l HeLa cell extract was precleared with 50 l glutathione- Microsequence analysis of proteins purified by gel electrophoresis.
agarose, followed by a second preclearing in GST-PGEX bound to In Methods in Neurosciences, M.P. Conn, ed. (San Diego: Academic
glutathione-agarose. The supernatant was incubated with 100 l Press), pp. 69–84.
GST-NF3 as above, and bound proteins were subjected to SDS-
Frank, M., and Kemler, R. (2002). Protocadherins. Curr. Opin. CellPAGE, transferred to PVDF membrane (MSI), and stained with amido
Biol. 14, 557–562.black. HPLC-purified tryptic fragments of the 39 and 41 kDa bands
Gumbiner, B.M. (1996). Cell adhesion: the molecular basis of tissuewere microsequenced using an ABI 470 protein sequencer (Fischer
architecture and morphogenesis. Cell 84, 345–357.et al., 1991).
Gumbiner, B.M. (2000). Regulation of cadherin adhesive activity. J.
Cell Biol. 148, 399–403.In Situ Hybridization and Immunohistochemistry
In situ hybridizations were performed using a probe corresponding Hardcastle, Z., and Papalopulu, N. (2000). Distinct effects of XBF-1
to the coding region of Xenopus TAF1, or an NFPC probe as de- in regulating the cell cycle inhibitor p27XIC1 and imparting a neural
scribed (Bradley et al., 1998). Immunohistochemistry of whole- fate. Development 127, 1303–1314.
mount embryos was performed as described (Bradley et al., 1998), Hensey, G., and Gautier, J. (1998). Programmed cell death during
using a TAF1/ monoclonal antibody (Matsumoto et al., 1999). For Xenopus development: a spatio-temporal analysis. Dev. Biol. 203,
confocal analysis, HeLa cells were grown on glass coverslips and 36–48.
transfected with NFPC-MT or N-Cad-MT using Effectene reagent
Hermiston, M.L., and Gordon, J.I. (1995). In vivo analysis of cadherin(Qiagen), fixed after 24 hr, and permeabilized with PBS containing
function in the mouse intestinal epithelium: essential roles of adhe-0.1% Triton X-100. Cells were then incubated in the 9E10 myc anti-
sion, maintenance of differentiation, and regulation of programmedbody and anti-human TAF1 antisera, followed by Cy3- and FITC-
cell death. J. Cell Biol. 129, 489–506.conjugated secondary antibodies, and viewed on a Leica TSC/SP
Hirano, S., Ono, T., Yan, Z., Wang, X., Sonta, S., and Suzuki, S.T.laser scanning confocal microscope.
(1999). Protocadherin 2C: a new member of the protocadherin 2
subfamily expressed in a redundant manner with OL-protocadherinMorpholino Experiments
in the developing brain. Biochem. Biophys. Res. Commun. 260,Antisense morpholinos (GeneTools) comprised the sequences 5	-
641–645.TCTGTGTCCCCTCAGTCCTCATCAT-3	 (NFPCMO) and 5	-CATGT
Kantak, S.S., and Kramer, R.H. (1998). E-cadherin regulates anchor-TGTGTGTGAGGAGAGGTGGT-3	 (TAF1MO), as well as a standard
age-independent growth and survival in oral squamous cell carci-control morpholino (CMO). For BrdU and TUNEL analysis, 1–5 M
noma cells. J. Biol. Chem. 273, 16953–16961.of morpholino was coinjected with nLacZ RNA into a single eight-cell
blastomere, fixed at stage 22, and processed for -galactosidase Kim, S.H., Yamamoto, A., Bouwmeester, T., Agius, E., and Robertis,
activity; for immunoblot analysis, morpholinos were injected into E.M. (1998). The role of paraxial protocadherin in selective adhesion
both cells of a two-cell embryo and harvested at stage 17. To exam- and cell movements of the mesoderm during Xenopus gastrulation.
ine mitosis, embryos were injected with BrdU (Hardcastle and Pa- Development 125, 4681–4690.
palopulu, 2000) 2 hr prior to fixing, and then immunostained using Kim, S.H., Jen, W.C., DeRobertis, E.M., and Kintner, C. (2000). The
an anti-BrdU antibody (Boehringer Mannheim). TUNEL assays were protocadherin PAPC establishes segmental boundaries during so-
performed on whole-mount morpholino-injected embryos ac- mitogenesis in Xenopus embryos. Curr. Biol. 10, 821–830.
cording to protocol (Hensey and Gautier, 1998). Embryos were seri-
Kintner, C.R., and Melton, D.A. (1987). Expression of Xenopusally sectioned and in every third section the number of TUNEL-
N-CAM RNA in ectoderm is an early response to neural induction.positive nuclei per injected side was counted and an average was
Development 99, 311–325.obtained for 8–12 embryos for each morpholino.
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